H2-M3 Activators are a diverse array of chemical compounds that facilitate the enhancement of H2-M3's functional activity through their influence on various cellular signaling pathways. Forskolin, by elevating cAMP levels, indirectly promotes the functional role of H2-M3 in antigen presentation by activating PKA, which could phosphorylate proteins including H2-M3 to enhance its activity. Ionomycin and A23187, both calcium ionophores, raise intracellular calcium levels, potentially leading to the activation of calcium-dependent kinases that would favor H2-M3 phosphorylation and subsequent activation. PMA and Prostratin, as PKC activators, may augment signaling pathways that include kinases capable of phosphorylating H2-M3, thereby potentiating its role in immune response mechanisms. Meanwhile, agents like Ouabain and Valinomycin disrupt ion homeostasis, leading to increased intracellular sodium and calcium levels or altered membrane potential, respectively, which could activate pathways that involve H2-M3.
Further influencing H2-M3's activity are compounds that impact cellular processing and protein maturation. Brefeldin A and Monensin disrupt intracellular trafficking and pH, which can lead to enhanced antigen presentation by H2-M3 through modified glycosylation or altered peptide loading. Tunicamycin's inhibition of N-linked glycosylation may improve H2-M3's ability to present antigenic peptides by affecting its folding and stability. Similarly, Thapsigargin's inhibition of the SERCA pump results in increased cytosolic calcium levels, potentially activating kinases that promote H2-M3 activity. Cyclosporin A, through its inhibition of calcineurin, could alter T cell activation pathways in a way that indirectly supports the antigen-presenting function of H2-M3. Collectively, these H2-M3 Activators, through their targeted effects on intracellular signaling and protein processing, facilitate the enhancement of H2-M3 mediated functions within the immune system, particularly in the context of antigen presentation, without the need for upregulating its expression or direct activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent kinases that phosphorylate H2-M3, thereby enhancing its antigen-presenting function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a PKC activator, PMA can enhance signaling pathways that include kinases phosphorylating H2-M3, thus potentially enhancing its functional activity in immune responses. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that raises intracellular calcium levels, potentially leading to the activation of calcium-dependent kinases that may enhance H2-M3 activity. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the Na+/K+-ATPase pump, leading to increased intracellular sodium and calcium levels that could activate signaling pathways involving H2-M3 activation. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi apparatus function, which could lead to altered glycosylation and improved antigen presentation by H2-M3. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is a sodium ionophore that alters intracellular pH and sodium concentrations, which can influence signaling pathways and potentially enhance H2-M3's role in antigen presentation. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which may lead to altered folding and improved function of H2-M3 in presenting antigenic peptides. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, potentially activating signaling pathways that enhance the activity of H2-M3. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, leading to altered T cell activation pathways that may indirectly enhance the role of H2-M3 in antigen presentation. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $250.00 | 3 | |
Valinomycin is a potassium ionophore that can affect the membrane potential and ion homeostasis, possibly influencing signaling pathways that activate H2-M3. | ||||||